INDIVIDUALS ARE EXPOSED DAILY to a variety of inhaled toxic agents in different occupations and environmental settings, and many of these people may develop tolerance to adverse health effects from inhalation exposure. Tolerance can be defined as the ability to resist the injurious actions of a toxicant after continuous or repeated exposures. Tolerance has many implications for human health, with potentially advantageous and disadvantageous consequences. For example, individuals can be exposed to zinc oxide (ZnO) fumes from welding processes (11) , and acquisition of tolerance to the symptomatic effects of ZnO inhalation has been reported in clinical studies of metal fume fever (10, 14) and in a study of zinc foundry workers (42) . Pulmonary tolerance to the acute respiratory effects of ozone (O 3 ) has also been demonstrated in human subjects (8, 12, 17, 23, 24, 27) . Similar to the effect of repeated ZnO inhalation, induction of tolerance after repeated systemic endotoxin exposure is a favorable consequence that may avert the occurrence of septic shock (59) . On the other hand, acquisition of symptomatic tolerance to repeated exposure to endotoxins associated with cotton dust (9) and contaminated humidifiers (15) may occur initially but later may manifest as chronic lung disease (31, 60) .
In general, little is actually known about the molecular mechanism(s) of tolerance. Because the acquisition of pulmonary tolerance from repeated exposure to inhaled toxicants has ramifications for human health, the identification of innate and extrinsic factors that influence the ability to develop tolerance is a significant issue. Interindividual variability exists in the sensitivity to adverse respiratory effects from inhaled toxicants (1, 7, 40, 44) , suggesting that genetic background is a host factor for susceptibility. With regard to the phenotype of pulmonary tolerance, a study from our laboratory (14) has demonstrated that individuals vary in their initial response to inhaled ZnO as well as in their ability to develop systemic (e.g., symptoms and fever) and pulmonary tolerance. Similarly, interindividual variability has been shown in the development and persistence of pulmonary tolerance to O 3 (12, 27) . These studies suggest gene-environment interactions in human subjects.
Inhalation of ZnO has been shown to cause a marked inflammatory influx of polymorphonuclear leukocytes (PMNs) as well as changes in epithelial permeability in the lungs of humans and animals (4, 13, 22, 38, 39) . Exposure to ZnO fumes is also a major occupational respiratory hazard in many industrial processes (41) .
In the present study, we hypothesize that genetic background contributes to the acquisition of pulmonary tolerance to inhaled pollutants. Because inbred strains of mice are virtually identical at all loci and share several chromosomal regions of conserved synteny with humans, they are ideal for investigating genotype-environment interactions. Interstrain differences in the development of pulmonary tolerance were identified by measuring pulmonary inflammation and protein in bronchoalveolar lavage (BAL) fluid in 11 inbred strains of mice exposed both singly and repeatedly to ZnO fumes. In addition, the acquisition of pulmonary tolerance was examined in inbred mice exposed singly and repeatedly to O 3 or aerosolized endotoxin. Results from these studies demonstrated a significant genetic component in the ability to develop pulmonary tolerance to inhaled toxicants.
MATERIALS AND METHODS
Strain selection. All inbred mouse strains [A/J, AKR/J, C3H/HeJ, C3H/HeOuJ, BALB/cJ, BALB/cByJ (CBy), C57BL/ 6J, CBA/J, DBA/2J (D2), SJL/J, 129/J, and CByD2F1/J hybrid] were purchased from The Jackson Laboratory (Bar Harbor, ME). All mice were acclimated for at least 1 wk before exposure, housed in a positive-pressure environment with a 12:12-h light-dark cycle that started at 6:00 AM, and were provided with water and standard laboratory rodent chow (Purina, Indianapolis, IN) ad libitum except during exposure. The mice were handled in accordance with the standards established by the US Animal Welfare Acts set forth in National Institutes of Health guidelines and by the New York University School of Medicine Division of Laboratory Animal Resources.
Experimental design. To investigate the contribution of genetic background to the development of pulmonary tolerance, mice from 11 inbred strains were exposed to ZnO fumes once (1ϫ) or for 5 successive days (5ϫ) for 3 h/day. All 1ϫ exposures were done on the same day as the final 5ϫ exposure, and control animals were exposed to air. Acquisition of pulmonary tolerance was assessed by measuring inflammatory cellular influx and protein concentration in BAL fluid in a manner similar to that used in other investigations of tolerance to a variety of inhaled agents (2, 6, 20, 53) . Previously, our laboratory (56) demonstrated that pulmonary tolerance to PMN influx, but not lavageable protein and lung pathology, is developed in an outbred mouse model after repeated exposure to ZnO. Based on those observations, the pulmonary tolerance phenotype with respect to total BAL fluid PMNs and protein in the present study was characterized as 1) a significant decrease in mean lavageable PMNs between 1ϫ and 5ϫ exposure groups and 2) the absence of cumulative lung injury over the 5-day exposure period as measured by total protein in BAL fluid (no significant increase between the 1ϫ and 5ϫ exposure groups). Two inbred strains with markedly different PMN and protein responses to repeated ZnO exposure were identified: CBy (tolerant) and D2 (nontolerant). Total BAL fluid macrophage numbers were also determined in these two strains. To begin assessment of the mode of inheritance of pulmonary tolerance to ZnO exposure, total PMN and protein concentrations from a cross of the tolerant and nontolerant inbred strains (CByD2F1/J) were measured after 1ϫ and 5ϫ ZnO exposures. Dose-response effects on the development of ZnO-induced pulmonary tolerance were also studied in CBy and D2 mice. Lung pathology associated with 1ϫ and 5ϫ exposures to 1.0 mg/m 3 of
ZnO was determined to illustrate gross histopathological differences between the CBy and D2 strains. Furthermore, to evaluate whether the development of the tolerant and nontolerant phenotypes is agent specific, CBy and D2 mice were also singly and repeatedly exposed to O 3 and aerosolized endotoxin, and pulmonary tolerance was determined as described above.
Atmosphere generation and characterization. Mice were exposed to ZnO (1.0 Ϯ 0.2 and 2.1 Ϯ 0.2 mg/m 3 ; means Ϯ SD) in stainless steel cages placed inside a 0.07-m 3 Plexiglas chamber. ZnO fumes were generated in a furnace as previously described (43, 56) . The control (sham) exposures consisted of furnace gas composed of 97% filtered room air and 3% argon.
For endotoxin exposures, mice were placed in stainless steel cages inside a 0.05-m 3 Plexiglas chamber. Endotoxin and saline (control) aerosols were generated with a Babington-type nebulizer (Solosphere, Airlife, Modesto, CA) driven by high-efficiency particulate air (HEPA)-filtered air at 9 psi. The output of the nebulizer was diluted with HEPA-filtered air at 15 l/min before it entered the exposure chamber. Solutions of endotoxin (1.75 and 0.7 g/ml of lipopolysaccharide, Escherichia coli 0127:B8; Difco Laboratories, Detroit, MI) were made up with pyrogen-free, isotonic saline (0.9% sodium chloride, Baxter Healthcare, Deerfield, IL) immediately before exposure. The nebulizer reservoir was emptied and refilled at 1-h intervals during the exposures to minimize the concentrating effects of the nebulizer.
For O 3 exposures, mice were placed in stainless steel cages inside a 1-m 3 stainless steel inhalation chamber. O3 [0.60 Ϯ 0.02 parts/million (ppm)] was generated from 5% oxygen (balance argon) with an ultraviolet ozonator (OREC, Phoenix, AZ). O3 concentration was monitored in the breathing zone of the chamber with an O 3 detector (Dasibi model 1008-PC, Glendale, CA). This instrument was regularly calibrated against a US Environmental Protection Agency standard. Air (sham) exposures were also conducted for control purposes.
BAL. Twenty-four hours postexposure to ZnO, endotoxin, O3, air, or saline, mice were killed by intraperitoneal injections of ketamine hydrochloride (100 mg/kg; Vetalar, Fort Dodge Laboratories, Fort Dodge, IA) and pentobarbital sodium (175 mg/kg; Sleepaway, Fort Dodge Laboratories), and the posterior abdominal aorta was severed. The lungs of each mouse were lavaged two times with 1.2 ml of Dulbecco's phosphate-buffered saline without Ca 2ϩ or Mg 2ϩ (pH 7.2-7.4, 37°C; GIBCO BRL, Life Technologies, Grand Island, NY). Recovered BAL fluid was immediately placed on ice (4°C). Aliquots (100 l) of lavage fluid were cytocentrifuged (Cytospin, Shandon Southern Products), and the cells were stained with Hemacolor (EM Science, Gibbstown, NJ) for differential cell analysis. Differential cell counts were performed by identifying at least 200 cells according to typical cytological procedures (52) . Total cell counts were determined with a hemacytometer. The lavage fluid was then centrifuged (500 g, 7 min, 4°C), and the supernatant was decanted. The total protein concentration in the supernatant was measured with an assay kit (Pierce, Rockford, IL) that employs the method of Bradford (3) and is accurate from 10 to 2,000 g/ml (bovine serum albumin standard, 550 nm).
Tissue preparation and lung pathology. To obtain tissue for pathological analysis, mice were killed by intraperitoneal injections of pentobarbital sodium (175 mg/kg; Sleepaway), and a cannula (0.6-mm internal diameter) was inserted into the trachea. The lungs were deflated and then infused in situ with 2% glutaraldehyde, removed, and immersed in fixative for at least 24 h. Fixed tissues were dissected, and lung sections were dehydrated through a series of ethanol solutions and embedded in paraffin blocks. Paraffin-embedded tissues were sectioned (5 m), stained with hematoxylin and eosin, and examined by light microscopy. Several lung sections were evaluated for three mice per strain per exposure group, and the reader was blinded to strain and exposure at the time of evaluation. Histopathological changes including inflammatory cell influx, airspace infiltrates, and alveolar epithelium and septal wall thickening were assessed in lung sections from both the CBy and D2 strains.
Data analysis. ZnO-, O 3-, and endotoxin-induced changes in PMNs and protein in BAL fluid are presented as means Ϯ SE. Differences between means were assessed with a twofactor analysis of variance (ANOVA), and the factors for each analysis were strain and exposure. The Student-NewmanKeuls a posteriori test of significance was used to assess differences between means. Significance for all comparisons was accepted at P Ͻ 0.05.
RESULTS
Strain phenotype pattern of pulmonary tolerance to repeated ZnO exposure. Total PMN and protein concentrations in BAL returns from 11 inbred mouse strains were used to assess the development of pulmonary tolerance after 1ϫ and 5ϫ exposures to 1.0 Ϯ 0.2 mg/m 3 of ZnO (Table 1) . Statistical analysis by twoway ANOVA indicated significant effects of strain, exposure, and the interaction of strain and exposure on the mean number of PMNs (ϫ10 4 ) and total protein (g/ml) recovered by BAL (P Ͻ 0.05). Based on the aforementioned criteria for pulmonary tolerance, 6 of 11 inbred strains of mice (AKR/J, BALB/cJ, CBy, CBA/J, C3H/HeOuJ, SJL/J, and 129/J) exhibited a tolerant PMN response phenotype after 5ϫ exposure to ZnO. D2 and C3H/HeJ were the only strains that had a nontolerant phenotype with respect to total protein measured in BAL fluid (e.g., D2-1ϫ ϭ 579 Ϯ 55 g/ml; D2-5ϫ ϭ 1,338 Ϯ 78 g/ml; means Ϯ SE). Marked interstrain variation in the sensitivity to a 1ϫ ZnO exposure was also observed ( Table 1) .
Mode of inheritance and dose-response relationship. The CBy and D2 strains were determined to be tolerant and nontolerant, respectively, with regard to total PMN and protein endpoints in BAL fluid after five successive exposures to 1.0 mg/m 3 of ZnO. Total PMN and protein concentrations were not significantly different between the CBy and D2 strains after a 1ϫ exposure (P Ͼ 0.05). Compared with the 1ϫ exposure group, however, total PMNs returned to baseline values after 5ϫ exposures in the CBy strain but continued to increase in the D2 strain (Fig. 1A) . Similarly, ZnO had no effect on macrophage influx or protein in BAL fluid in 1ϫ or 5ϫ exposed CBy mice, but total macrophage and protein concentrations in BAL fluid were significantly increased in 5ϫ-exposed D2 mice compared with those exposed once (Fig. 1, B and C) . Total BAL fluid protein concentration and numbers of PMNs and macrophages from D2 mice exposed 5ϫ to ZnO were significantly greater than those of 5ϫ exposed CBy mice. To determine whether the development of pulmonary tolerance is a recessive or dominant trait, the offspring of a cross of the CBy and D2 strains (CByD2F1/J) were exposed 1ϫ and 5ϫ to 1.0 mg/m 3 of ZnO. CByD2F1/J mice were nontolerant, with total number of PMNs and protein concentrations not significantly different from those of the D2 progenitor strain after five exposures (P Ͼ 0.05; Fig. 1, A and C) . These findings suggest that pulmonary tolerance to repeated ZnO exposure is inherited as a recessive trait.
After 1ϫ and 5ϫ exposures to 2.0 mg/m 3 of ZnO, the CBy and D2 strains retained the tolerant and nontolerant phenotypes with regard to total PMNs and protein recovered from BAL fluid, respectively. Importantly, compared with a single 1.0 mg/m 3 ZnO exposure, CBy mice had a significantly greater total PMNs response after a 1ϫ exposure to 2.0 mg/m 3 of ZnO but were tolerant after five exposures (1ϫ ϭ 3.9 Ϯ 1.0 ϫ 10 4 PMNs; 5ϫ ϭ 0.7 Ϯ 0.2 ϫ 10 4 PMNs; Fig. 2A ). CByD2F1/J mice were nontolerant with respect to total PMN and protein after exposure to 2.0 mg/m 3 of ZnO. Unlike the response to 1.0 mg/m 3 of ZnO, the total protein in BAL fluid was significantly increased over control values in CBy mice after both the 1ϫ and 5ϫ exposures to 2.0 mg/m 3 of ZnO (Fig. 2C ) but did not Values are means Ϯ SE; nos. in parentheses, no. of mice. Twenty-four hours after either single (1ϫ) or repeated (5ϫ; once daily for 5 consecutive days) 3-h exposures to 1.0 mg/m 3 of zinc oxide (ZnO) or air (control), changes in total polymorphonuclear leukocytes (PMNs; ϫ10 4 ) and total protein (g/ml) were measured in the bronchoalveolar lavage (BAL) fluid of 11 inbred strains of mice. Significantly different (P Ͻ 0.05) from: * air-exposed control mice; † mice in 1ϫ exposure group. increase over the 5-day exposure period. Additionally, total numbers of macrophages were significantly increased between 1ϫ and 5ϫ exposures to 2.0 mg/m 3 of ZnO in the CBy strain (Fig. 2B) .
Pulmonary histopathology induced by single and repeated ZnO exposure. Exposure-induced changes in pulmonary histology were evaluated in tolerant CBy mice and nontolerant D2 mice. No marked strain differences in histopathology were observed after a 1ϫ exposure to 1.0 mg/m 3 of ZnO (Fig. 3, A and B) . Compared with 5ϫ exposed CBy mice, however, more airspace infiltrates (Fig. 3, C and D) , alveolar septal wall thickening (Fig. 3, E and F) , and alveolar congestion of inflammatory cells were found in lung sections of D2 mice (Fig. 3, C-F) . These observations are consistent with the aforementioned ZnO-induced differences in total PMNs, macrophages, and protein in BAL fluid after 1ϫ and 5ϫ exposures.
Pulmonary tolerance to repeated O 3 and aerosolized endotoxin exposure. After 1ϫ and 5ϫ exposures of CBy and D2 mice to 0.6 ppm O 3 or aerosolized endotoxin, total PMN, macrophage, and protein concentrations were used to determine whether the development of pulmonary tolerance was agent specific. Similar to that seen with ZnO exposure, total PMNs were significantly increased over those in control mice after a single exposure to O 3 in the CBy strain, and these mice were tolerant to PMNs and protein in BAL fluid (Fig. 4, A and C). Unlike the response to 5ϫ ZnO exposure, however, total macrophages were significantly increased over control level in 5ϫ O 3 -exposed CBy mice (Fig. 4B) . Additionally, in the D2 strain, there were very few PMNs in both 1ϫ and 5ϫ O 3 -exposed mice (1ϫ ϭ 0.2 Ϯ 0.03 ϫ 10 4 PMNs; 5ϫ ϭ 0.5 Ϯ 0.2 ϫ 10 4 PMNs; Fig. 4A ) compared with ZnO-exposed mice. Total BAL fluid protein in D2 mice, however, continued to increase between the O 3 exposure groups (1ϫ ϭ 478 Ϯ 39 g/ml; 5ϫ ϭ 677 Ϯ 25 g/ml; Fig. 4C ) similar to that seen with ZnO exposure, although this increase was not statistically significant (P Ͼ 0.05). With respect to single and repeated exposure to aerosolized endotoxin (generated from a 1.75 g/ml solution), in the CBy strain, total PMNs were significantly increased over those in control mice after a single exposure, and these mice were tolerant to PMNs in BAL fluid after five successive exposures (Fig. 5A) . However, D2 mice, which were nontolerant to ZnO, developed tolerance to repeated endotoxin exposure. The D2 strain exhibited a significant decrease in total PMNs between 1ϫ and 5ϫ endotoxin exposure groups (1ϫ ϭ 4.8 Ϯ 1.1 ϫ 10 4 ; 5ϫ ϭ 0.7 Ϯ 0.3 ϫ 10 4 ; Fig. 5A ). Single and repeated endotoxin exposure had little effect on total BAL fluid macrophage and protein concentrations in CBy and D2 mice compared with those in control mice (Fig. 5, B and C) . BAL fluid protein concentrations in the D2 strain, however, significantly decreased between the 1ϫ and 5ϫ exposure groups (Fig. 5C) . Similar results were obtained with a lower concentration of aerosolized endotoxin (generated from a 0.7 g/ml solution; data not shown).
DISCUSSION
In previous human and animal studies, PMNs and protein in BAL fluid have been used as indexes of lung injury to assess the development of pulmonary tolerance after repeated exposure to various inhaled agents. One of the primary objectives of this study was to determine whether the development of pulmonary tolerance to repeated toxicant exposure has a genetic component. Previous investigations (26, 28, 32, 46, 49, 51, 57) have used inbred mouse strains to determine that genetic background plays an important role in susceptibility to oxidant gas-and particle-induced pulmonary inflammation and lung injury. In the present study, we evaluated total PMNs and protein in BAL fluid after 1ϫ and 5ϫ exposures to 1.0 mg/m 3 of ZnO in 11 inbred strains of mice. We found significant interstrain (i.e., genetic) variation in the acquisition of pulmonary tolerance to repeated ZnO exposure, which supports the hypothesis that the development of tolerance in inbred mice has a significant genetic element. Additionally, our data suggest that PMN infiltration and increased BAL fluid protein are not mutually dependent events and may be controlled by different genes (or loci). This agrees with our previous study of ZnO tolerance in an outbred mouse model (56) as well as with other investigations of inbred mice exposed to inhaled nickel sulfate (57) . Our ZnO tolerance data from CBy mice are most consistent with the development of endotoxin tolerance, which exhibits a significantly diminished PMN response, whereas protein in BAL fluid remains unaltered (53, 54) .
In the present study, the CBy and D2 inbred strains were determined to be the most tolerant and nontolerant, respectively, to ZnO challenge. To determine whether pulmonary tolerance to ZnO is inherited as a dominant or recessive trait, CByD2F1/J mice were phenotyped for response to repeated exposure to 1.0 mg/m 3 of ZnO. The cellular and protein responses of 5ϫ exposed CByD2F1/J mice were not different from those of nontolerant D2 mice, suggesting that pulmonary tolerance to repeated ZnO exposure is inherited as a recessive trait. The development of tolerance, however, is likely under the control of multiple genes. Additional genetic analyses with CBy and D2 offspring (e.g., backcrosses or intercrosses) may better clarify this interpretation.
To investigate whether the development of pulmonary tolerance depends on ZnO concentration, CBy, D2, and CByD2F1/J mice were exposed 1ϫ and 5ϫ to 2.0 mg/m 3 of ZnO. The CBy strain retained tolerance to PMNs and protein in BAL fluid after five successive exposures, despite significantly greater PMN and protein responses in 1ϫ exposed mice compared with those of the group exposed to 1.0 mg/m 3 of ZnO. Unlike the response elicited by 1.0 mg/m 3 of ZnO, however, there was a significant increase in the numbers of macrophages between 1ϫ and 5ϫ exposures to 2.0 mg/m 3 of ZnO in CBy mice. Additionally, the D2 strain remained nontolerant after 1ϫ and 5ϫ exposure to 2.0 mg/m 3 of ZnO, but the 1ϫ PMN and protein responses were not different from those of mice exposed to 1.0 mg/m 3 of ZnO. These data suggest that in this genetic model, there are dose-response effects of inhaled ZnO on lavageable PMN, protein, and macrophage concentrations in 1ϫ and 5ϫ exposed CBy and D2 inbred mice. Furthermore, the development of tolerance to cellular influx and protein in BAL fluid after five successive ZnO exposures appears to be independent of the magnitude of the initial 1ϫ responses with the two ZnO exposure concentrations used in this study. It is unknown, however, if tolerance to lavageable PMNs and protein in the CBy strain is eventually ablated at a higher ZnO exposure concentration.
The mechanism(s) of tolerance to inhaled pollutants is not well understood, and the literature is limited regarding the genes that control this response. Many investigators have hypothesized that the development of pulmonary tolerance to inhaled toxicants may be a result of the production of a multitude of protective Fig. 3 . Lung histology of BALB/cByJ and DBA/2J mice 24 h after 1ϫ or 5ϫ exposure to 1.0 mg/m 3 of ZnO for 3 h. Tissues were fixed with 2% glutaraldehyde, embedded in paraffin, stained with hematoxylin and eosin, and viewed by light microscopy. A: 1ϫ BALB/cByJ (ϫ200). B: 1ϫ DBA/2J (ϫ200). C: 5ϫ BALB/cByJ (ϫ200). D: 5ϫ DBA/2J (ϫ200). E: 5ϫ BALB/cByJ (ϫ400). F: 5ϫ DBA/2J (ϫ400). No marked strain differences in histopathology were observed after 1ϫ ZnO exposure (A and B). D: 5ϫ exposed DBA/2J mice had more alveolar congestion of inflammatory cells (arrows) compared with 5ϫ exposed BALB/cByJ mice (C). F: 5ϫ exposed DBA/2J mice had a greater amount of alveolar septal wall thickening (arrows) compared with 5ϫ exposed BALB/cByJ mice (E).
biological molecules such as antioxidants (58) , antioxidant enzymes (18, 30) , stress proteins (21, 56) , specific cytokines (16, 30, 45) , and pulmonary surfactant (47) . Additionally, it has been suggested that similar molecular mechanisms may control the development of pulmonary tolerance to repeated toxicant exposure. For example, preexposure to O 3 (29) , endotoxin (19) , nitrogen dioxide (5), or cadmium aerosol (25) produces cross-tolerance to hyperoxia in rats by reducing lung injury and lethality.
In the present study, CBy and D2 mice were exposed to ZnO, O 3 , or aerosolized endotoxin to determine whether the development of pulmonary tolerance is agent specific. Similar to their response to ZnO exposure, the CBy strain was tolerant to increased PMNs and protein in BAL fluid after repeated exposure to O 3 and endotoxin. This suggests that a common mechanism (or collection of genes) may be responsible for the pathogenesis of pulmonary tolerance to repeated toxicant exposure in the CBy strain. Likewise, D2 mice remained nontolerant to protein in BAL fluid after five successive O 3 exposures, although it was unclear whether they were tolerant to O 3 -induced PMNs in BAL fluid. In contrast to the response to ZnO exposure, the D2 strain developed tolerance to PMNs and protein in BAL fluid after repeated exposure to aerosolized endotoxin. The disparity in phenotypes between ZnOand endotoxin-exposed D2 mice is indicative that a different molecular mechanism(s) may regulate the acquisition of pulmonary tolerance to repeated ZnO and endotoxin exposure in the D2 strain. Taken together, these data suggest that the development of tolerance to lung injury from repeated toxicant exposure is a complex trait, and the manifestation of the tolerance phenotype may be agonist dependent.
To identify the candidate genes that may play a role in pulmonary tolerance, we are currently conducting a formal linkage analysis of tolerant and nontolerant phenotypes in segregant populations derived from the CBy and D2 strains. Linkage analyses are expected to produce valuable information on the genetic mechanisms involved in the pathogenesis of pulmonary tolerance, similar to that provided by previous investigations of susceptibility to O 3 -and particle-induced lung injury (35, 48, 50, 51) . In the present study, the role of the Toll-like receptor 4 (Tlr4) gene in ZnO tolerance was determined by comparing pulmonary responses in C3H/HeJ and C3H/HeOuJ mice as described previously with O 3 and acid-coated particles (36, 37, 49) . Similar to what was observed with O 3 , the C3H/HeOuJ strain (homozygous for the wild-type Tlr4 allele) was significantly more sensitive to ZnO-induced protein in BAL fluid than the C3H/HeJ strain (homozygous for a mutant Tlr4 allele) after a 1ϫ exposure (Table 1) . Unlike what was seen with acid-coated particle-induced lung inflammation, however, C3H/HeOuJ mice were more susceptible than C3H/HeJ mice to ZnOinduced PMNs in BAL fluid after a single exposure to 1.0 mg/m 3 of ZnO. Tlr4 did not appear to confer tolerance to ZnO-induced lung injury after five successive exposures because C3H/HeOuJ mice displayed a tolerant phenotype with regard to PMNs and protein in BAL fluid. It is unclear from our data, however, whether Tlr4 regulates the nontolerant phenotype because of the lack of PMN and protein responses after a single exposure in the C3H/HeJ strain.
Inferences regarding genetic mechanisms can be made by comparing the relative sensitivities to lung injury among inbred strains exposed to O 3 (32) (33) (34) or nickel sulfate (57) . In general, the C3H/HeJ strain appears to be the most resistant to changes in BAL PMNs and protein from single O 3 (acute, 2 ppm for 3 h; subacute, 0.3 ppm for 48 h), nickel sulfate (150 g of Ni/m 3 for 48 h), and ZnO (1.0 mg/m 3 for 3 h) exposures. Conversely, the D2 strain appears to be resistant to the adverse pulmonary effects from acute and subacute O 3 exposure but was quite sensitive to both 1ϫ and 5ϫ ZnO exposures. Likewise, C57BL/6J mice were susceptible to O 3 -and nickel sulfate-induced PMNs and protein in BAL fluid but were relatively resistant to single and repeated ZnO exposure. Due to differences in the development of tolerance between intermittent and continuous O 3 exposure (55), caution must be taken when interpreting the comparison of 5ϫ ZnO responses with those from subacute O 3 and nickel sulfate exposures. However, the discordance in responses among the inbred mice used in these studies suggests that separate genes may control susceptibility to PMNs and protein in BAL fluid, not only within a given strain, but also between different types of inhaled agonists.
In summary, we have found that significant interstrain variation exists in the acquisition of pulmonary tolerance to repeated ZnO exposure. Thus the development of tolerance has a significant genetic component. CByD2F1/J mice were also examined to determine the mode of inheritance of pulmonary tolerance. Furthermore, comparison of phenotypes between CBy and D2 inbred mice after repeated exposure to O 3 and aerosolized endotoxin suggested that the development of pulmonary tolerance is controlled via multiple molecular mechanisms. This model will be useful in determining candidate genes that play important roles in these mechanisms and may help in the understanding of the human health effects of repeated pollutant exposure.
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